… published since our last update in May are listed below. The MIBs review relevant published evidence and the likely costs of new technologies. They are designed to be fast, flexible and responsive to the need for information on innovative technologies. MIBs are commissioned by NHS England. Further details are available
here.
- OCS Heart system for heart transplant
- CytoSorb therapy for sepsis
- Sternal Talon for sternal closure in cardiothoracic surgery
- Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventions
- UrgoStart for chronic wounds
- Woundchek Protease Status for assessing elevated protease status in chronic wounds
- Absorb Bioresorbable Vascular Scaffold for coronary artery disease
- Needle-free arterial non-injectable connector
- QuikRead go for C-reactive protein testing in primary care
- VitalPAC for assessing vital signs of patients in hospital
- FLEXISEQ for osteoarthritis
- Alere Afinion CRP for C-reactive protein testing in primary care
- Axxent electronic brachytherapy system for early stage breast cancer
- OSNA for colon cancer staging
- Alair bronchial thermoplasty system for adults with severe difficult to control asthma
- Lutonix drug-coated balloon for peripheral arterial disease
- QTUG for assessing falls risk and frailty
- Stretta System for gastro-oesophageal reflux disease
- S-Cath System for suprapubic catheterisation
- Cellvizio confocal endomicroscopy system for characterising pancreatic cysts
- Mobi-C for cervical disc replacement
- CareLink network service for remote monitoring of people with cardiac devices
- Prolaris gene expression assay for assessing long-term risk of prostate cancer progression
- Secca System for faecal incontinence
- LATITUDE NXT Patient Management System for monitoring cardiac devices at home
